1.
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
by Davis, T. M. E
Diabetologia, 2010-11-04, Vol.54 (2), p.280-290
2.
Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?
by Niemelä, S
Heart (British Cardiac Society), 1996-06, Vol.75 (6), p.573-575
3.
Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction : the FINAMI study
by PAJUNEN, P
Diabetologia, 2005, Vol.48 (12), p.2519-2524
4.
The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes
by PÖYKKÖ, S. M
Diabetologia, 2005, Vol.48 (2), p.309-316
5.
Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland
by KAPRIO, J
Diabetologia, 1992, Vol.35 (11), p.1060-1067
6.
Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects
by PÖYKKÖ, S
Diabetologia, 2003, Vol.46 (4), p.455-458
7.
Heart rate variability in systemic hypertension
by Huikuri, Heikki V
The American journal of cardiology, 1996, Vol.77 (12), p.1073-1077
8.
Variation at the Angiotensin-Converting Enzyme Gene and Angiotensinogen Gene Loci in Relation to Blood Pressure
by Kiema, Tiila-Riikka
Hypertension (Dallas, Tex. 1979), 1996-12, Vol.28 (6), p.1070-1075
9.
The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects
by Niemi, M
Gut, 1999-04, Vol.44 (4), p.557-562
10.
Pre-Eclampsia Is a Risk Factor of Carotid Artery Atherosclerosis
by Haukkamaa, L
Cerebrovascular diseases (Basel, Switzerland), 2009-05, Vol.27 (6), p.599-607
11.
Heart Rate Variability and Baroreflex Sensitivity in Hypertensive Subjects With and Without Metabolic Features of Insulin Resistance Syndrome
by Pikkujämsä, Sirkku M
American journal of hypertension, 1998, Vol.11 (5), p.523-531
12.
Dispersion of the QT Interval and Autonomic Modulation of Heart Rate in Hypertensive Men With and Without Left Ventricular Hypertrophy
by Perkiomaki, Juha S
Hypertension (Dallas, Tex. 1979), 1996-07, Vol.28 (1), p.16-21
13.
Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations
by Dégano, Irene R
Heart (British Cardiac Society), 2015-09, Vol.101 (17), p.1413-1421
14.
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
by Keech, A
The Lancet (British edition), 2005, Vol.366 (9500), p.1849-1861
15.
The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colest...
by KORHONEN, T
European journal of clinical pharmacology, 1999, Vol.54 (12), p.903-910
16.
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitu...
by UKKOLA, O
Journal of molecular medicine (Berlin, Germany), 1995, Vol.73 (6), p.307-311
17.
Serum Triglycerides and Clinical Benefit in Lipid-Lowering Trials
by Kesaniemi, Y Antero
The American journal of cardiology, 1998, Vol.81 (4), p.70B-73B
18.
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer
by Niemi, Mari
Journal of epidemiology and community health (1979), 2000-12, Vol.54 (12), p.938-939
19.
Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors
by KAUMA, H
Human genetics, 1996, Vol.97 (2), p.156-162
20.
Effects of early administration of enalapril on radionuclide left ventricular ejection fraction and plasma N-terminal atrial natriuretic peptide after acute myocardial infarction
by Kettunen, Raimo V.J
The American journal of cardiology, 1994, Vol.73 (12), p.865-867
